Daily Anesthesiology Research Analysis
Today’s top anesthesiology research spans perioperative nerve block strategy to preserve hemodialysis access, device selection for one-lung ventilation, and interpretable AI to predict PACU complications. A double-blind RCT shows stellate ganglion block improves arteriovenous fistula patency, a meta-analysis contrasts double-lumen tubes with bronchial blockers, and a large prospective cohort delivers a multi-label model for simultaneous PACU risk prediction.
Summary
Today’s top anesthesiology research spans perioperative nerve block strategy to preserve hemodialysis access, device selection for one-lung ventilation, and interpretable AI to predict PACU complications. A double-blind RCT shows stellate ganglion block improves arteriovenous fistula patency, a meta-analysis contrasts double-lumen tubes with bronchial blockers, and a large prospective cohort delivers a multi-label model for simultaneous PACU risk prediction.
Research Themes
- Perioperative regional anesthesia to protect vascular access in high-risk patients
- Device optimization for one-lung ventilation in thoracic anesthesia
- Interpretable machine learning for PACU complication prediction
Selected Articles
1. Stellate ganglion block for preserving arteriovenous fistula in hemodialysis patients undergoing major lower limb orthopedic surgeries: randomized control trial.
In a double-blind RCT of 50 hemodialysis patients undergoing major lower limb orthopedic surgery, preemptive stellate ganglion block significantly increased AV fistula flow on postoperative days 1 and 7, improved PSV/EDV, lowered RI, and reduced thrombosis (8% vs 36%) and functional failure (32% vs 64%). Findings support SGB as a perioperative strategy to preserve AVF patency in high-risk patients.
Impact: This trial provides randomized, double-blind evidence that a widely available regional block can meaningfully reduce AVF thrombosis and failure in a vulnerable population, addressing a critical perioperative complication.
Clinical Implications: Consider integrating ultrasound-guided SGB before neuraxial anesthesia in hemodialysis patients undergoing major limb surgery to protect AVF patency, coupled with Doppler surveillance and standard thrombosis prevention.
Key Findings
- SGB increased AVF flow on POD1 (276.96±49.66 vs 217.44±46.73 ml/min) and POD7 (254.96±49.38 vs 204.56±47.11 ml/min), p<0.001.
- Improved PSV/EDV and lower RI after SGB versus control.
- Lower thrombosis (8% vs 36%) and functional failure (32% vs 64%) rates with SGB.
Methodological Strengths
- Randomized, double-blind, sham-controlled design with CONSORT adherence
- Objective Doppler ultrasonography endpoints assessed on two postoperative time points
Limitations
- Single-center study with modest sample size (n=50)
- Short follow-up limited to 7 postoperative days and specific to lower limb orthopedic surgery
Future Directions: Multicenter RCTs with longer follow-up should confirm durability of AVF patency benefits, explore optimal timing/dose, and assess generalizability to other surgeries.
BACKGROUND: Major lower limb orthopedic surgeries can lead to hemodynamic alterations and increase the risk of arteriovenous (AV)fistula thrombosis. This study assessed the role of stellate ganglion block (SGB) in preserving the AV fistulas in hemodialysis (HD)patients undergoing major lower limb orthopedic surgeries. METHODS: In this randomized, controlled, double-blind trial, 50 chronic renal failure patients (ASA physical status III, aged 21-75 years) scheduled for major lower limb orthopedic surgeries were randomized into two groups: Group S received an ultrasound-guided SGB before spinal anesthesia, while Group C received a sham procedure. AVF function was assessed using Doppler ultrasonography on postoperative days 1 and 7. Primary outcome was AVF flow rate. Secondary outcomes included peak systolic velocity (PSV), end-diastolic velocity (EDV), resistive index (RI), thrombosis rate, and functional failure. RESULTS: Group S demonstrated significantly higher AVF flow rates on both postoperative day 1 (276.96 ± 49.66 ml/min vs. 217.44 ± 46.73 ml/min) and day 7 (254.96 ± 49.38 ml/min vs. 204.56 ± 47.11 ml/min), with large effect sizes (Cohen's d = 1.23 and 1.04, respectively; p < 0.001). PSV and EDV were significantly improved, and RI was significantly lower in Group S. Thrombosis (8% vs. 36%) and failure rates (32% vs. 64%) were significantly reduced compared to the control group (p < 0.05). CONCLUSIONS: Pre-emptive stellate ganglion block was associated with significantly improved AVF flow rate postoperatively and reduced thrombosis and functional failure, suggesting its clinical benefit in maintaining AVF patency during major surgeries in HD patients. TRIAL REGISTRATION: This study was approved by the Ethical Committee of Aswan University Hospitals, Egypt (Institutional Review Board (IRB 900/2/24)) and registered on clinicaltrials.gov (ID: NCT06300658). The registration time of this experiment is 3/09/2024. The study protocol was designed and implemented in accordance with the CONSORT guidelines. The study protocol was conducted in compliance with the relevant guidelines and standards.
2. Interpretable multi-label classification model for predicting post-anesthesia care unit complications: a prospective cohort study.
In 16,838 adults after general anesthesia, an interpretable multi-label model predicted six PACU complications with AUCs up to ~0.93 and quantified inter-complication dependencies via a Markov network. Key predictors included age, sex, BMI, anesthesia duration, and postoperative analgesia, with respiratory events showing strongest performance and influence on hemodynamic instability.
Impact: Demonstrates at scale that interpretable AI can concurrently predict multiple PACU complications and reveal actionable dependencies, enabling proactive perioperative management.
Clinical Implications: Hospitals can leverage interpretable multi-label risk scores to triage monitoring intensity, preempt respiratory events, and tailor analgesia to reduce downstream hemodynamic instability, while maintaining transparency for clinical adoption.
Key Findings
- Among 16,838 patients, 40.6% had ≥1 PACU complication; 57% had ≥2 concurrent complications in training cohort.
- AUCs for six complications ranged ~0.69–0.93 across cohorts; respiratory adverse events performed best.
- Top predictors: age, sex, BMI, anesthesia duration, postoperative analgesia; respiratory events strongly influenced hemodynamic instability within the Markov network.
Methodological Strengths
- Large prospective cohort with dynamic PACU monitoring
- Interpretable modeling (SHAP) and Markov network to quantify inter-complication associations
Limitations
- Likely single-center dataset; external multicenter validation not reported
- Predictive performance does not equate to demonstrated clinical outcome improvement
Future Directions: Prospective, multicenter impact studies should test EHR integration, workflow alerts, and whether targeted interventions guided by the model reduce PACU events and resource use.
BACKGROUND: There are potential associations between post-anesthesia care unit (PACU) complications that significantly impact enhanced recovery after surgery. Timely identification of these signs is essential for implementing comprehensive, systematic management strategies and delivering personalized anesthetic care. However, relevant studies are currently limited. This study aimed to develop and validate an interpretable multi-label classification model to predict PACU complications concurrently. METHODS: This prospective cohort study enrolled adult patients who underwent general anesthesia and elective surgery and were transferred to the PACU after surgery. The patients were dynamically monitored and evaluated for the occurrence of six common PACU complications: respiratory adverse events, hypothermia, hemodynamic instability, nausea/vomiting, agitation/delirium, and pain. A multi-label classification model was developed on the basis of 16 key features, and a Markov network was embedded to quantify and analyze the association network among these complications. The SHapley Additive exPlanations (SHAP) method was applied to conduct interpretability analysis of the model. RESULTS: Of the 16,838 total patients, 6,830 (40.6%) experienced at least one complication. In the training cohort, 2,125 (57.0%) patients experienced two or more complications at the same time. The AUCs for the six complications in the three cohorts ranged from 0.735 to 0.914, 0.720 to 0.920, and 0.693 to 0.928, respectively. Respiratory adverse events performed best. Age, gender, BMI, duration of anesthesia, and postoperative analgesia emerged as the five most important features. The relative importance of respiratory adverse events to hemodynamic instability was the highest. CONCLUSION: The integration of a multi-label classification model with interpretable methods has significant advantages in simultaneously predicting PACU complications, identifying the risk factors for specific complications, optimizing postoperative resource allocation, and improving patient outcomes.
3. Efficiency and safety of double-lumen bronchial tube and bronchial blocker for one-lung ventilation in patients with thoracic surgery: a meta-analysis.
Across 39 RCTs (n=2709), double-lumen tubes achieved faster/better lung collapse, whereas bronchial blockers enabled shorter positioning times and lower rates of airway-related complications and hypoxemia/pneumonia. Findings support individualized OLV device selection balancing operative exposure with postoperative safety.
Impact: This meta-analysis synthesizes randomized evidence to clarify trade-offs between DLBT and BB, informing evidence-based device choice in thoracic anesthesia.
Clinical Implications: Prefer DLBT when optimal lung collapse quality is paramount; consider BB for faster positioning or when minimizing airway trauma and postoperative complications is prioritized.
Key Findings
- Included 39 RCTs with 2709 patients (BB 1360; DLBT 1349).
- DLBT provided superior lung collapse quality and shorter lung collapse time.
- BB had shorter positioning time and reduced risks of hoarseness, sore throat, tracheal injury, hypoxemia, and pneumonia.
Methodological Strengths
- Exclusive inclusion of RCTs with dual independent screening and data extraction
- Risk-of-bias assessed by Cochrane tool and certainty summarized with GRADE
Limitations
- Heterogeneity in outcome definitions and operator techniques across trials
- Abstracted outcomes focus on perioperative metrics; long-term airway outcomes not addressed
Future Directions: Head-to-head pragmatic trials stratifying by surgical approach and airway difficulty, with standardized lung collapse scoring and patient-centered outcomes, are warranted.
OBJECTIVES: To compare the efficiency and safety of double-lumen bronchial tube (DLBT) and bronchial blocker (BB) for one-lung ventilation (OLV) in patients with thoracic surgery. METHODS: A systematic search was conducted across Chinese databases and English databases from the inception of the databases until December 31, 2024. Two researchers independently screened the literature and extracted data. A meta-analysis was then performed using Review Manager 5 and Stata 18.0 software. The quality of the studies was assessed using the Cochrane bias risk assessment tool, and a summary of findings (SoF) table was generated using GRADEprofiler Version 3.6.1. RESULTS: A total of 39 RCTs were included, comprising 1360 patients in the BB group and 1349 patients in the DLBT group. The excellent rate of lung collapse quality in the BB group was 0.94 times that in the DLBT group [I CONCLUSION: The DLBT group demonstrated certain advantages in terms of lung collapse time and quality of lung collapse. However, BB demonstrate significantly shorter positioning time compared to DLBT, and it is also associated with lower risks of multiple complications, including hoarseness, sore throat, tracheal injury, hypoxemia, and pneumonia, highlighting its safety advantage in postoperative care.